Literature DB >> 22707740

Plasma proteins for risk prediction in idiopathic pulmonary fibrosis.

Thomas J Richards, Naftali Kaminski, Kevin F Gibson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22707740      PMCID： PMC5448581          DOI： 10.1164/ajrccm.185.12.1329

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  5 in total

1.  Risk prediction in idiopathic pulmonary fibrosis.

Authors:  Brett Ley; Harold R Collard
Journal:  Am J Respir Crit Care Med       Date:  2012-01-01       Impact factor: 21.405

2.  Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis.

Authors:  Harold R Collard; Carolyn S Calfee; Paul J Wolters; Jin Woo Song; Sang-Bum Hong; Sandra Brady; Akitoshi Ishizaka; Kirk D Jones; Talmadge E King; Michael A Matthay; Dong Soon Kim
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-04-23       Impact factor: 5.464

3.  Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis.

Authors:  Thomas J Richards; Naftali Kaminski; Fred Baribaud; Susan Flavin; Carrie Brodmerkel; Daniel Horowitz; Katherine Li; Jiin Choi; Louis J Vuga; Kathleen O Lindell; Melinda Klesen; Yingze Zhang; Kevin F Gibson
Journal:  Am J Respir Crit Care Med       Date:  2012-01-01       Impact factor: 21.405

4.  Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis.

Authors:  Roland M du Bois; Derek Weycker; Carlo Albera; Williamson Z Bradford; Ulrich Costabel; Alex Kartashov; Lisa Lancaster; Paul W Noble; Ganesh Raghu; Steven A Sahn; Javier Szwarcberg; Michiel Thomeer; Dominique Valeyre; Talmadge E King
Journal:  Am J Respir Crit Care Med       Date:  2011-08-15       Impact factor: 21.405

5.  Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis.

Authors:  Brent W Kinder; Kevin K Brown; Francis X McCormack; Joachim H Ix; Alma Kervitsky; Marvin I Schwarz; Talmadge E King
Journal:  Chest       Date:  2009-03-02       Impact factor: 9.410
  5 in total
  3 in total

1.  BAL Cell Gene Expression Is Indicative of Outcome and Airway Basal Cell Involvement in Idiopathic Pulmonary Fibrosis.

Authors:  Antje Prasse; Harald Binder; Jonas C Schupp; Gian Kayser; Elena Bargagli; Benedikt Jaeger; Moritz Hess; Susanne Rittinghausen; Louis Vuga; Heather Lynn; Shelia Violette; Birgit Jung; Karsten Quast; Bart Vanaudenaerde; Yan Xu; Jens M Hohlfeld; Norbert Krug; Jose D Herazo-Maya; Paola Rottoli; Wim A Wuyts; Naftali Kaminski
Journal:  Am J Respir Crit Care Med       Date:  2019-03-01       Impact factor: 21.405

2.  Cutaneous T-cell-attracting chemokine as a novel biomarker for predicting prognosis of idiopathic pulmonary fibrosis: a prospective observational study.

Authors:  Takafumi Niwamoto; Tomohiro Handa; Yuko Murase; Yoshinari Nakatsuka; Kiminobu Tanizawa; Yoshio Taguchi; Hiromi Tomioka; Keisuke Tomii; Hideo Kita; Michihiro Uyama; Michiko Tsuchiya; Masahito Emura; Tetsuji Kawamura; Naoki Arai; Machiko Arita; Kazuko Uno; Akihiko Yoshizawa; Ryuji Uozumi; Izumi Yamaguchi; Fumihiko Matsuda; Kazuo Chin; Toyohiro Hirai
Journal:  Respir Res       Date:  2021-06-17

3.  Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells.

Authors:  Yong Huang; Justin M Oldham; Shwu-Fan Ma; Avraham Unterman; Shu-Yi Liao; Andrew J Barros; Catherine A Bonham; John S Kim; Rekha Vij; Ayodeji Adegunsoye; Mary E Strek; Philip L Molyneaux; Toby M Maher; Jose D Herazo-Maya; Naftali Kaminski; Bethany B Moore; Fernando J Martinez; Imre Noth
Journal:  Am J Respir Crit Care Med       Date:  2021-07-15       Impact factor: 30.528
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.